... to a population-based observational study published in JAMA Psychiatry.
Treatment with a central stimulant may reduce the risk of suicide attempt and nonsuicidal self-injury in adults with a dual diagnosis of bipolar disorder and attention-deficit/hyperactivity disorder (ADHD), ...
...according to a study published online in Therapeutic Advances in Psychopharmacology.
....and generalized anxiety disorder (GAD) among people with cannabis use disorder.
Some 18.1% of patients who tested positive for COVID-19 in the United States were diagnosed with a psychiatric disorder within 3 months, according to a study published in The Lancet Psychiatry.
...from those who are Caucasian, and those differences may influence their response to specific medications, according to a genomic-level study published in Scientific Reports.
... reduce relapse and recurrence of major depressive disorder (MDD), whether or not pharmacotherapy was continued, researchers found in a systematic review and meta-analysis.
...according to a comprehensive review and meta-analysis published online in Psychiatry Research.